Duo Oncology Inc.DO
SEC Form D filing

Duo Oncology Inc.

Biotech · Series A · Regulation D 506(b) · PA · Filed June 9, 2026

Offering amount
$3.0M
Exemption
Reg D 506(b)
Issuer state
PA
Filing date
June 9, 2026
Signature date
June 8, 2026
CIK
0001843372

Summary

Auto-generated

oncology biotech company, $3M Series A in PA

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.